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ABSTRACT
A quantitative relationship between hemagglutination titer and animal toxicity of type A botulinum toxin was demonstrated utilizing a modification of the hemagglutination procedure of Rosenfield et al. Hemagglutination titer was correlated to animal toxicity by measuring hemagglutinin activity of known concentrations of toxic material with an established mouse intraperitoneal LD50 value. The automated procedure employed is accurate and reproducible in the range of 5 to 50 pg toxin per ml. 
CONTENTS

I. INTRODUCTION
Estimation of the potency of botulinal toxin usually depends upon a dose-response relationship in animals. Tests wuch as the Oudin are not necessarily reliable indexes of toxic potency because toxicity decays more easily than antigenicity. Another objection to immunodiffusion tests is the nresence nf fise precipitin bands that may result from impurities in the toxin. Lamanna and Lowenthal 1 showed that cryetaliiute type A toxin produces two precipitin bands with specific antisera, but only one when the hemagglutinin has been absorbed from the toxin. They also observed that a cross reaction occurs between type A hemagglutinin and specific B antitoxin.
Because of the limitations of in vitro tests for botulinal toxin, most investigations to improve assay procedures have been directed toward improvement of the animal test. Such tests are frequently affected by inconsistent results. The development of laboratory identification procedures not dependent upon animal tests would save much time and eliminate costly assay procedures.
The agglutinating properties of type A toxin were investigated by Lamanna and Lowenthal and Lamanna 1 5 as a possible indicator of toxic activity. They observed that under the influence of varying physical factors, the relationship between toxicity and hemagglutination is not constant and agglutinating capacity does not necessarily indicate activity of toxin in all cases. However, if these physical factors are controlled within a standard set of conditions, one may hypothesize that for a given hemagglutination titer, a precise amount of toxicity will be represented. By using a toxic material with an established mouse intraperitoneal (MIP) LDS value, it seems possible to correlate hemagglutination titers with LDse values. Such data might then be used to prepare a standard hemagglutination curve in which the LDS value could be interpreted at any point.
Rosenfield, Szymanski, and Kochwa s designed a system of automatic analysis in which the parameters affecting hemagglutination could be closely controlled. This system, with some modification in design and reagent, appeared applicable to a more detailed study of botulinal hemagglutination. The objective of this investigation was to determine whethcr. in this system, a standard procedure could be developed to establish correlations between hemagglutination titer and MIPLDg values of type A botulinum toxin. The assays were performed at ambient temperature. Samples were mixed with the erythrocyte suspension f or approximatel.y 3 minutes to permit adsorption of toxin. Then polyvinylpyrrolidone was added to induce rouleau formation. After further mixing of sample and reagent f or 5 to 6 minutes, PBS con~taining 1 drop Tween 20 per liter (Atlas Powder Co.) was introduced into the system to resu.pend nonagglutinated cells. The agglutinated cells were allowed to fall out in a settling coil and were removed by siphoning. The nonagglutinated cells were lysed by introducing the Triton X-100 solution. The resulting 'hemoglobin color was read at 550 m4L and recorded. Quantitation was based on the hemoglobin content of nonagglutinated erythrocytes.
F. HEMAGGLUTINATION INHIBITION
Salmples of toxin were prepared in PBS from partially purified dried material. Antitoxin was sofrially diluted with PBS to 1:512. Equal volumes of these dilutions were added to equal volumes uf the toxin solution and allowed to react for 45 minutes at ambient temperature. The samples were then assayed as in the hemagglutination technique.
G. ANIMAL TESTS
Homogeneous Swiss white mice (Animl Farm, Fort Detrick), 16 to 20 g, were inoculated intraperitoneally with O.5-ml samples of toxin. FUM: ='11 determinations, five diluticn points were used for each sample,, 10 mice for each point. Dilutions of samples were prepa;;ed using 0.27. gel-phosphate diluent. All animals were held for at least 4 days. A probic analystis was performed to obtain the LDg value of each of the samples.
RESULTS
Initial experiments used both purified and partially purified dried toxin, using material weight as a basis itt comparing sampleas assayed. However, subsequent work utilized only the partially purified dried toxin becauue it was more readily available and more stable. Crystalline toxtin prepared in concentrations ranging from I to 1,000 pg/al was te.jtod to obtain the system range. The omt linear curve could be plotted fro concentrations between 5 to 50 4/u1. A typical hamaglutination titer of purified toxin is ahown in Figure 2 . When the partiall *y purified dried toxin was tasted In a simlar mnner, the agglutinating activity was approaimately 10 to 11%. of that of pure toxic. Consequently, the operational concentration was Incrased to a range between 50 to S00 41.1l, total weight basis.
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Standard curves for hemagglutination values were prepared in the automated system for 50, 100, 200, 300, and 500 1g/ml concentrations of the partially purified toxin. Dilutions from four identical 0.1-g samples of this toxin were assayed in mice, and a mean value of 4.5 x 10 MIPLDS/g was obtained. For purified material, the toxicity reported by Schantz? was 2.4 x 108 + 207. MIPLDN/mg N. Using the conversion factor of 1,000/6.25, the toxicity per gram of crystalline toxin would be 3.8 x 1010 MIPLDS. This compares favorably with the hemag lutination titer of the partially pure toxin; i.e., 4.5 x 109 / 3.8 x 1010 is approximately 12%. LDW values were assigned to the standard curves for relatil4 material weight with probit values. By correlating these values, it was unnecessary to compensate for the iidirect proportions between constant volumes of erythrocytes and increases in hemagglutinin titer that were observed by Lowenthale and Lamannao 4 Other factors suggested by those authors as affecting the hemagglutinin-toxicity relationships were easily controlled in this system. All volumes, reaction times, and temperatures were held constant. A stable pH of 6.8 was obtained by using the PBS in preparing all reagents and dilutions of samples. To ensure that temperature outside the system had no effect, all samples were prepared and assayed immediately under identical conditions either in the hemagglutination system or in mice for confirmatory tests.
The accuracy and reproducibility of the automated system in performing hemagglutination tests were statistically analyzed. Four carefully weighed 0.l-g samples of the partially purified dried material were dissolved
S in a known amount of PBS and then divided into two subsamples. Each of these
samples was used to prepare 50. 100, 200, 300, and 500 pg/ml concentrations of the maerial. These concentrations were assayed twice so that, for each point in a standard curve, there was a total of sixteen replicates. Confidence limits for the mean of each concentration tested, expressed in per cent light transmission, are shown in Table 1 . The analysis of variance (Table 2) showed that there was no statistically significant variation (95% confidence) among samples or between aliquots within samples. In order to show that agglutination of the erythrocytes was actually7 being caused by the toxin, specific antitoxin was serially diluted with PBS and mixed in eaual volumes with partially purified toxin at 250 gg/ml. The resulhs of this test, illustrated in Figure 3 , showed that no agglutination occurred in the presence of specific antitoxin except for those dilutions in which complete neutralization apparently did not occur. This conclusion was substantiated by mouse tests in the following experiment. Each of these toxin-antitoxin samples were inoculated intraperitoneally into 10 groups of five mice each. Those samples that showed a slight i hemagglutination reaction with 1:8 and 1:16 dilutions of specific antitoxin killed the challenged mice within 12 hours. The samples in which agglutination was definitely inhibited had no effect on the mice. The data are shown in Figure 3 . This result appears to be at variance with Lamanna and Lowenthal's data, 1 which indicated that type A antitoxin neutralizes hemagglutinins and toxin disproportionately.
The possibility of using this hemagglutination system in estie.ting the toxic activity in liquid cultures was also investigated. Type A toxin was produced in thioglycollate and in N-Z-Amine, type B media. Samples were assayed after 3 to 4 days of bacterial cell growth in each culture. Samples of each of the cultures were prepared by removing cell debris by centrifugation for 10 minutes at 5,000 x g.
Toxirt was demonstrable by hemagglutination in the N-Z-Ainne culture superriatant but thise samples grown in thioglycollate medium showed almost no agglutination. Evidently the hemagglutinin was partially bound with media components. When the crude toxin supernatant from the thioglycollate cultures was titrated to pH 3.5 with N OCI, a precipitate was formed. This precipitate was washed and rediluted to original volume with PBS,, and agglutination occurred as expected upon assay. To test the effect of the thioglycollate medium upon hemagglutination., a 50 1g/ml sample of purified toxin vas added to an equal volume of sterile thioglycollate medium. As a control, a simiLar sample was prepared in PBS. Remagglutination tests were then pet-formed on PBS, sterile thioglycollate medium, a centrifuged thioglycollate culture supernatant, sterile thioglycollate medium plus toxin, and PBS plus toxin. These tests showed that in the presence of thioglycollate medium almost no agglutination occurred. The results are shown graphically in Figure 4 . The estimated pure toxin concentrations are based upon the approximate value of 4.5'x 10 9 MIPLDMg of partially purified dried toxin.
As indicated, the N-Z-Amine, type B culture supernatant agglutinated the erythrocytes without any prior treatment of the sample. To determine if the toxin actually caused the observed agglutination, we divided the sample into two parts. One part was filtered through an EK Seitz filter before assay in either the hemagglutination system or in mice. The adsorptive qualities of these filters have been assessed. 9 ' 0 l The other part of the supernatant was tested without any treatment. The hemagglutination titer of the sample without treatment (Fig. 5) predicted a biological activity of,6.7 x 10 5 MIPLDS/ml. When inoculated at a 10 5 dilution into a group of 10 mice. five died in 4 days. The sample that passed through the Seitz filter showed no agglutination ( Fig. 5) and had no effect when inoculated into mice.
IV. DISCUSSION
Good agreement was obtained between hemagglutinin titer and toxicity of pure and partially purified tcxin. When considered on a toxin-toweight ratio, the hemagglutinin titer of partially purified toxin indicated that it was approximately 10 to 11% of that of pure toxin. When assayed in animals. the percentage of toxicity of the partially purified toxin was approximately 11.8% by weight.
The addition of specific antitoxin to the toxic samples tested showed that a definite relationship existed between hamagglutinin titer and toxicity. Where hemagglutination was completely inhibited by antitoxin, there was no effect on laboratory animals when inoculated with these mixtures. When the test animals were inoculated with the samples in which inhibitiorn was inccmplete, the progressive time to death data shown in Figure 3 were observed.
A set of experiments was performed to establish what relationship existed between samples of known toxicity and those of culture supernatants. The indications were that supernatant.samples could be estimated provided substances such as those present in a thioglycollate medium were not present. This system my have application in both the detection and quantitative estimation of type A bottvlinum toxin. If a material is suspected of containing toxin, a hemagglutination reaction within the system would indicate qualitatively that toxin may be present. Reaction with specific antitoxin would determine whether agglutination was caused by a type A toxic product or was nonspecific.
Hemagglutination cross reactions with type B toxin are recognized. In this respect, further testing is needed to determine whether agglutination inhibition is the sLue with type B antitoxin, or whether differences in inhibition patterns between types can be detected ii the automated system. Vermilyea, Walker, and Ayres I ' observed nc cross reactions between type A and type K or type B and type E, using the Ouchterlony technique. Botulinal types C and D toxicoses are nearly nonexistent in humqns. Therapy after defined sympto usually consists of administration of bivalent A-B antitoxin. It has been suggested that therapy for suspected botulinum poisoning include either the A-B-E antitoxin mixture, or the pentavalent human antitaxin. 3 In any event, the hemagglutination phenomena permit a rapid presumptive test for at least type A toxin. Demonstrable presence oU toxin in quantitative values would be of considerable value therapeutically, because the complete procedure for an unkn.on can be performed in 20 minutes.
The hemgglutination proceduze may also have use in titrating the protective strength of specific antisera. Inhibition of agglutination by serially diluted antitoxinj using a standardized toxin or toxoid, could be used to determine the relative strengths of various antitoxic sera. Conversely, if the potency of the antitoxin it known, it is possible to relate toxicity of an unknown sauple in terms relative to the antitc~in.
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